Dirk A Lamprecht (Dirk Lamprecht)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Microbiology spectrum

PLoS pathogens

Nature communications

Antioxidants (Basel, Switzerland)

Janssen Pharmaceutica NV

Stellenbosch University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Pharmaceutica NV Apr 01 2018

Belgium

Scientist :: Infectious Diseases & Vaccines

Africa Health Research Institute Feb 01 2013 - Feb 09 2018

South Africa

Postdoc :: Steyn Lab

Education History

Stellenbosch University Mar 01 2008 - Dec 01 2012

South Africa

PHD :: Biochemistry

Publications

Natalia Smiejkowska, Lauren Oorts, Kevin Van Calster, Linda De Vooght, Rob Geens, Henri-Philippe Mattelaer, Koen Augustyns, Sergei V Strelkov, Dirk A Lamprecht, Koen Temmerman, Yann G-J Sterckx, Davie Cappoen, Paul Cos
A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors. Microbiology spectrum 12 (3) (2024)
Natalia Smiejkowska, Lauren Oorts, Kevin Van Calster, Linda De Vooght, Rob Geens, Henri-Philippe Mattelaer, Koen Augustyns, Sergei V Strelkov, Dirk A Lamprecht, Koen Temmerman, Yann G-J Sterckx, Davie Cappoen, Paul Cos
A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors. Microbiology spectrum 12 (3) (2024)
Natalia Smiejkowska, Lauren Oorts, Kevin Van Calster, Linda De Vooght, Rob Geens, Henri-Philippe Mattelaer, Koen Augustyns, Sergei V Strelkov, Dirk A Lamprecht, Koen Temmerman, Yann G-J Sterckx, Davie Cappoen, Paul Cos
A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors. Microbiology spectrum (2024)
Natalia Smiejkowska, Lauren Oorts, Kevin Van Calster, Linda De Vooght, Rob Geens, Henri-Philippe Mattelaer, Koen Augustyns, Sergei V Strelkov, Dirk A Lamprecht, Koen Temmerman, Yann G-J Sterckx, Davie Cappoen, Paul Cos
A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors. Microbiology spectrum 12 (3) (2024)
Tafara T R Kunota, Md Aejazur Rahman, Barry E Truebody, Jared S Mackenzie, Vikram Saini, Dirk A Lamprecht, John H Adamson, Ritesh R Sevalkar, Jack R Lancaster, Michael Berney, Joel N Glasgow, Adrie J C Steyn
Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility. Antioxidants (Basel, Switzerland) 10 (8) (2021)
Jared S Mackenzie, Dirk A Lamprecht, Rukaya Asmal, John H Adamson, Khushboo Borah, Dany J V Beste, Bei Shi Lee, Kevin Pethe, Simon Rousseau, Inna V Krieger, James C Sacchettini, Joel N Glasgow, Adrie J C Steyn
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nature communications 11 (1) (2020)
Andréanne Lupien, Shi-Yan Caroline Foo, Svetlana Savina, Anthony Vocat, Jérémie Piton, Natalia Monakhova, Andrej Benjak, Dirk A Lamprecht, Adrie J C Steyn, Kevin Pethe, Vadim A Makarov, Stewart Thomas Cole
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis. PLoS pathogens 16 (1) (2020)
Vikram Saini, Krishna C Chinta, Vineel P Reddy, Joel N Glasgow, Asaf Stein, Dirk A Lamprecht, Md Aejazur Rahman, Jared S Mackenzie, Barry E Truebody, John H Adamson, Tafara T R Kunota, Shannon M Bailey, Douglas R Moellering, Jack R Lancaster, Adrie J C Steyn
Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis. Nature communications 11 (1) (2020)
Bridgette M Cumming, Md Aejazur Rahman, Dirk A Lamprecht, Kyle H Rohde, Vikram Saini, John H Adamson, David G Russell, Adrie J C Steyn
Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection. PLoS pathogens 13 (5) (2017)

Dirk A Lamprecht.css-eqlu8i{font-size:small;padding-left:4px;} (Dirk Lamprecht)

Publication Activity (10 Years)

Top Topics

Top Venues

Dirk A Lamprecht (Dirk Lamprecht)